BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 8627342)

  • 1. Expression of growth factors and growth factor receptors in capillary hemangioblastoma.
    Böhling T; Hatva E; Kujala M; Claesson-Welsh L; Alitalo K; Haltia M
    J Neuropathol Exp Neurol; 1996 May; 55(5):522-7. PubMed ID: 8627342
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexpression of erythropoietin and vascular endothelial growth factor in nervous system tumors associated with von Hippel-Lindau tumor suppressor gene loss of function.
    Krieg M; Marti HH; Plate KH
    Blood; 1998 Nov; 92(9):3388-93. PubMed ID: 9787178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathology, genetics and cell biology of hemangioblastomas.
    Wizigmann-Voos S; Plate KH
    Histol Histopathol; 1996 Oct; 11(4):1049-61. PubMed ID: 8930647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Putative control of angiogenesis in hemangioblastomas by the von Hippel-Lindau tumor suppressor gene.
    Stratmann R; Krieg M; Haas R; Plate KH
    J Neuropathol Exp Neurol; 1997 Nov; 56(11):1242-52. PubMed ID: 9370235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Wizigmann-Voos S; Breier G; Risau W; Plate KH
    Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Central nervous system capillary haemangioblastoma: the pathologist's viewpoint.
    Hussein MR
    Int J Exp Pathol; 2007 Oct; 88(5):311-24. PubMed ID: 17877533
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endothelial cells by inactivation of VHL gene direct angiogenesis, not vasculogenesis via Twist1 accumulation associated with hemangioblastoma neovascularization.
    Wang Y; Chen DQ; Chen MY; Ji KY; Ma DX; Zhou LF
    Sci Rep; 2017 Jul; 7(1):5463. PubMed ID: 28710479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological study of vascular endothelial growth factor (VEGF), p53, and proliferative potential in familial von Hippel-Lindau disease and sporadic hemangioblastomas.
    Miyagami M; Katayama Y; Nakamura S
    Brain Tumor Pathol; 2000; 17(3):111-20. PubMed ID: 11310918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Notch receptor and effector expression in von Hippel-Lindau disease-associated central nervous system hemangioblastomas.
    Merrill MJ; Edwards NA; Lonser RR
    J Neurosurg; 2011 Sep; 115(3):512-7. PubMed ID: 21663414
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Study of angiogenic signaling pathways in hemangioblastoma.
    Pierscianek D; Wolf S; Keyvani K; El Hindy N; Stein KP; Sandalcioglu IE; Sure U; Mueller O; Zhu Y
    Neuropathology; 2017 Feb; 37(1):3-11. PubMed ID: 27388534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evolution of VHL tumourigenesis in nerve root tissue.
    Vortmeyer AO; Tran MG; Zeng W; Gläsker S; Riley C; Tsokos M; Ikejiri B; Merrill MJ; Raffeld M; Zhuang Z; Lonser RR; Maxwell PH; Oldfield EH
    J Pathol; 2006 Nov; 210(3):374-82. PubMed ID: 16981244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecularly genetic analysis of von Hippel-Lindau associated central nervous system hemangioblastoma.
    Zhou J; Wang J; Li N; Zhang X; Zhou H; Zhang R; Ma H; Zhou X
    Pathol Int; 2010 Jun; 60(6):452-8. PubMed ID: 20518900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas.
    Hatva E; Böhling T; Jääskeläinen J; Persico MG; Haltia M; Alitalo K
    Am J Pathol; 1996 Mar; 148(3):763-75. PubMed ID: 8774132
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression and activation of epidermal growth factor receptor in hemangioblastomas.
    Chen GJ; Karajannis MA; Newcomb EW; Zagzag D
    J Neurooncol; 2010 Sep; 99(2):195-200. PubMed ID: 20730556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibin alpha distinguishes hemangioblastoma from clear cell renal cell carcinoma.
    Hoang MP; Amirkhan RH
    Am J Surg Pathol; 2003 Aug; 27(8):1152-6. PubMed ID: 12883249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinicopathologic study of von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J; Li NY; Zhou XJ; Zhou HB; Wu B; Jiang SJ; Ma HH; Zhang RS
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):145-50. PubMed ID: 20450758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of vascular endothelial growth factor in cerebellar hemangioblastomas does not correlate with tumor angiogenesis.
    Vaquero J; Zurita M; Coca S; Salas C; Oya S
    Cancer Lett; 1998 Oct; 132(1-2):213-7. PubMed ID: 10397476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.
    Wanebo JE; Lonser RR; Glenn GM; Oldfield EH
    J Neurosurg; 2003 Jan; 98(1):82-94. PubMed ID: 12546356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advance in von Hippel-Lindau syndrome-related and sporadic hemangioblastomas of central nervous system].
    Zhou J; Li NY; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Mar; 39(3):212-5. PubMed ID: 20450775
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.